Andrew Cuthbertson

Andrew Cuthbertson

Director/Board Member at ZENYTH THERAPEUTICS LIMITED

Net worth: 13 M $ as of 2024-02-28

70 year
Health Technology
Consumer Services
Government

Profile

Presently, Andrew Cuthbertson occupies the position of Chief Scientific Officer & Executive Director at CSL Ltd. and Chief Scientific Officer of CSL Behring LLC (a subsidiary of CSL Ltd.). He is also on the board of CSL Innovation Pty Ltd., Centre for Eye Research Australia and Grattan Institute and Council Member at the University of Melbourne. Andrew Cuthbertson previously occupied the position of Senior Scientist at Genentech, Inc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-15 70,391 ( 0.01% ) 13 M $ 2024-02-28

Andrew Cuthbertson active positions

CompaniesPositionStart
ZENYTH THERAPEUTICS LIMITED Director/Board Member -
CSL LIMITED Director/Board Member 2018-10-16
Director/Board Member 2017-12-31
Corporate Officer/Principal 2015-12-31
Centre for Eye Research Australia Director/Board Member 2017-02-28
Director/Board Member 2018-12-31
All active positions of Andrew Cuthbertson

Former positions of Andrew Cuthbertson

CompaniesPositionEnd
Corporate Officer/Principal 1996-12-31
See the detail of Andrew Cuthbertson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Cuthbertson's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
CSL LIMITED

Health Technology

Private companies5

Health Technology

Health Technology

Health Technology

Centre for Eye Research Australia

Government

Commercial Services

See company connections
  1. Stock
  2. Insiders
  3. Andrew Cuthbertson